A case of cutaneous plasmacytoma treated with thalidomide

Eul Sang Hwang, Sang Wook Son, Il Hwan Kim

Research output: Contribution to journalArticlepeer-review


Cutaneous involvement has been reported in all types of malignant plasma cell disorders including multiple myeloma, solitary myeloma of bone, plasma cell leukemia, and extramedullary plasmacytoma. But metastatic plasmacytomas in the skin are rare in multiple myeloma and extramedullary plasmacytoma. If skin tumors appear during the course of multiple myeloma, these should be interpreted as a sign of poor prognosis. Treatment of patients with resistant multiple myeloma is challenging. Thalidomide has recently shown antitumor activity in patients with refractory myeloma. Until the introduction of thalidomide, no drugs other than cytotoxic agents and glucocorticoids had shown antitumor activity to cutaneous plasmacytoma. We recently performed a clinicopathologic study of a patient with cutaneous involvement of multiple myeloma and reported our result with thalidomide therapy in this patient.

Original languageEnglish
Pages (from-to)1325-1328
Number of pages4
JournalKorean Journal of Dermatology
Issue number10
Publication statusPublished - 2004 Oct


  • Cutaneous plasmacytoma
  • Thalidomide

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'A case of cutaneous plasmacytoma treated with thalidomide'. Together they form a unique fingerprint.

Cite this